Eqis Capital Management, Inc. Nuvasive Inc Transaction History

Eqis Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$43.51 - $66.59 $141,494 - $216,550	-3,252 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$32.82 - $81.13 $7,811 - $19,308	-238 Reduced 6.82%	3,252 $247,000
Q4 2019 Jan 24, 2020	SELL	$60.96 - $77.7 $53,096 - $67,676	-871 Reduced 19.97%	3,490 $270,000
Q3 2019 Nov 05, 2019	BUY	$55.78 - $68.08 $243,256 - $296,896	4,361 New	4,361 $276,000
Q4 2018 Jan 25, 2019	SELL	$47.64 - $71.26 $309,850 - $463,475	-6,504 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$52.03 - $71.41 $338,403 - $464,450	6,504 New	6,504 $459,000
Q2 2018 Jul 27, 2018	SELL	$48.15 - $56.68 $386,114 - $454,516	-8,019 Closed	0 $0
Q1 2018 Apr 06, 2018	BUY	$46.03 - $61.28 $369,114 - $491,404	8,019 New	8,019 $419,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.